http://www.cps.ca/english/statements/FN/fn96-01.htm

"Given an 85-year life expectancy, these investigators calculated that the expected lifetime cost of routine neonatal circumcision was $164.61 per patient, and the quality-adjusted survival was 84.999 years. For those not circumcised, the expected mean lifetime cost was $139.26 per patient and the quality-adjusted survival was 84.71 years. The investigators therefore concluded there was no medical indication for circumcision or contraindication against it. According to their sensitivity analyses, if the rate of surgical complications of neonatal circumcision fell below the threshold value of 0.6%, then circumcision would be preferred, both in terms of its cost and its favourable effect on lifespan. Similarly, if the risk of penile problems among uncircumcised males rose to 17% from the baseline value of 14%, then circumcision would be preferred from a cost perspective."